Nationwide survey of Cockayne syndrome in Japan: Incidence, clinical course and prognosis
Abstract
In the first nationwide survey of Cockayne syndrome (CS) in Japan, the incidence of CS was estimated to be 2.77 per million births (95%CI: 2.19-3.11) and the prevalence was approximately 1 in 2,500,000. A total of 47 CS patients (24 surviving and 23 deceased) were identified. Based on clinical course, these 47 patients were classified into CS type 1 (n = 41; 21 surviving, 20 deceased), CS type 2 (n = 2; all deceased), CS type 3 (n = 3; all surviving), and CS/xeroderma pigmentosum type D (n = 1, deceased). In the 41 CS type 1 patients, seven findings (i.e. failure to thrive; photosensitivity; deafness; characteristic facial appearance of CS [sunken eyes]; foot joint contracture; intellectual disability; and basal ganglia calcification on computed tomography [CT]) were observed in >90% of patients. Of these, failure to thrive, photosensitivity, and intellectual disability (language delays) developed before 2 or 3 years of age, whereas deafness, sunken eyes, and basal ganglia calcification on CT occurred later. Features such as bodyweight and height stagnation, language delay, abnormal nutritional pathways (tube feeding), and renal failure were more prominent in the 20 deceased CS type 1 patients than in the 21 surviving CS type 1 patients. Of the 20 deceased CS type 1 patients, nine developed severe renal failure during the terminal stages of their condition. The present findings suggest that the clinical course of CS includes a diverse range of symptoms, but each type has char…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
No known CS patient has ever developed cancer.
“In contrast to XP-C patients, no known CS patient has ever developed cancer (4, 5, 8).”
From Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency (2016) · cites this paper as [8]
Cited by
Sorted by citations
Cockayne syndrome: Clinical features, model systems and pathways
Karikkineth, A. C., Scheibye-Knudsen, M., Fivenson, E., Croteau, D. L., & Bohr, V. A. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.002 · Cited by 262 · see citing works
Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency
Reid-Bayliss, K. S., Arron, S. T., Loeb, L. A., Bezrookove, V., & Cleaver, J. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610020113 · Cited by 55 · see citing works
Absence of skin cancer in the DNA repair-deficient disease Cockayne Syndrome (CS): a survey study
Zhang, W. R., Garrett, G. L., Cleaver, J. E., & Arron, S. T. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.003 · Cited by 19 · see citing works
- Authors
- Kubota, M., Ohta, S., Ando, A., Koyama, A., Terashima, H., Kashii, H., Hoshino, H., Sugita, K., & Hayashi, M.
- Affiliations
- National Center For Child Health and Development (JP)
- Chiba University (JP)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Kubota, Masaya
- Venue
- Pediatrics International
- Publisher
- Wiley
- Published
- 2015-06
- Volume
- 57
- Issue
- 3
- Pages
- 339-347
- ISSN
- 1328-8067 (ISSN-L)
- 1442-200X
- OpenAlex
- W2146761804
- Cited by
- 50
- References
- 0
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 1 · 2018: 6 · 2017: 3 · 2016: 4 · 2015: 1
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pediatrics International (publishedVersion)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (25515008, 25282033)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and rare skin diseases.
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- Cockayne syndrome, incidence, prevalence, clinical course, prognosis, failure to thrive, photosensitivity, intellectual disability, deafness, basal ganglia calcification, renal failure, dietary management
- MeSH terms
- Cockayne Syndrome, Humans, Japan, Prognosis, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review